PHARMA FUTUR

Active

Private limited companyfounded 20224 yrs activeRue de l'Avenir 12, 4890 Thimister-Clermont, BelgiumKBO/BCE: BE 0787.394.827

PHARMA FUTUR has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (€-244k) and a net result of €-270k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 8% of 7740 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.4% (low).

Watch Print / PDF

Checked score

Score 2025

26 / 100

Weak

The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.

Axes · tick = 2024

Profitability0▼-73

Solvency0▼-28

Growth32▼-46

Track record94

Bankruptcy probability, 12 months

1.4% Low

0%0.5%1.5%4%10%≥ 25%

No credit on open account

Liquidity short (current ratio 0.53 against 0.68 in 2024; short-term debt: 58.6% and cash: 0.1% of total assets), and equity is negative.

How do we compute the score and the probability?

Credit advice for your own amount and term

Signals

Eight signals. The signal on the left, the evidence on the right.

−lowers risk+raises risk○neutral

Limited track record

This company has not been active as long as an established one and statistically fails somewhat more often.

KBO · incorporation date

Age against the risk zone

Lower-failure-rate sector

In this sector companies fail less often than the Belgian average.

Gazette · bankruptcies per sector, NACE 82

Relative position

BE, all sectors

reference

Sector 82

lower

← fewer bankruptcies more bankruptcies →

Annual accounts: weaker financial profile

The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.

NBB · annual accounts 2025

Solvency, return and age of the figures

Solvency

-38.8%

Return on assets

-42.9%

Age of the figures

9 mo

Higher-failure-rate region

In this region companies fail more often than in the rest of the country.

KBO · registered office

Negative equity

The 2025 annual accounts show negative equity and a net loss.

NBB · annual accounts 2025

Equity per financial year

22232425

2022 to 2025 · latest year €-244k

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-07-2026, 8 days ahead of the deadline.

NBB · 4 filings

Deviation from the deadline

2025

8 d early

2024

61 d late

2023

31 d late

2022

46 d late

← before the deadline after the deadline →

The next deadline is still running

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.

Companies Code · seven months

Position in the running window

22-09-2026 today31-12-2026 close31-07-2027 deadline

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity

€-244k

2024 · €25k

2022: €22k 2023: €-2k 2024: €25k

2022 → 2025

Total assets

€629k▼ 20.4%

2024 · €791k

2022: €36k 2023: €11k 2024: €791k

2022 → 2025

Net result

€-270k

2024 · €27k

2022: €22k 2023: €-24k 2024: €27k

2022 → 2025

Working capital

€-172k▼ 8.4%

2024 · €-158k

2022: €13k 2023: €-8k 2024: €-158k

2022 → 2025

Multi-year overview

Available amounts per fiscal year

Line2022202320242025Trend

Equity€22k-€-2k€25k€-244k

Operating result€22k-€-21k€43k€-245k

Net result€22k-€-24k€27k€-270k

Turnover and EBIT margin not published: the micro schema does not require them.

Result per fiscal year

Operating resultNet result

The operating result turns negative in 2025: a loss of €245k after €43k in 2024, the lowest result in the available series.

Balance-sheet composition

2025 in colour, 2024 as the grey bar beneath

Assets €629k

68.7%

31.3%

Fixed assets €432k▼ 5.8%

Current assets €197k▼ 40.6%

Key figures and ratios

2025 value · change against 2024

EBITDA

€-193k▼

2024 · €51k

Cash flow

€-218k▼

2024 · €35k

Solvency

-38.8%▼

2024 · 3.2%

Current ratio

0.53▼

2024 · 0.68

Quick ratio

0.08▼

2024 · 0.30

Debt / equity

-3.57▼

2024 · 30.19

ROA

-42.9%▼

2024 · 3.4%

Interest coverage

-7.58▼

2024 · 6.04

Debt

€874k▲

2024 · €765k

Debt ≤ 1 year

€369k▼

2024 · €490k

Debt > 1 year

€503k▲

2024 · €275k

Income taxes

€204▼

2024 · €9k

Staff costs

€178k▲

2024 · €29k

Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.

Filed annual accounts

As filed with the NBB · 2025 against 2024

Balance sheet Code20242025

Assets

Total assets20/58€791k€629k▼

Fixed assets21/28€459k€432k▼

Intangible fixed assets21€321k€289k▼

Tangible fixed assets22/27€138k€144k▲

Plant, machinery and equipment23-€1k

Furniture and vehicles24€53k€41k▼

Leasing and similar rights25€5k€4k▼

Other tangible fixed assets26€80k€98k▲

Current assets29/58€332k€197k▼

Stocks and contracts in progress3€185k€168k▼

Stocks30/36€185k€168k▼

Amounts receivable within one year40/41€136k€18k▼

Trade receivables40€88k€18k▼

Other amounts receivable41€48k-

Cash at bank and in hand54/58€7k€395▼

Deferred charges and accrued income490/1€4k€10k▲

Equity and liabilities

Total equity and liabilities10/49€791k€629k▼

Equity10/15€25k€-244k▼

Reserves13€25k-

Distributable reserves133€25k-

Profit (loss) carried forward14-€-244k

Amounts payable17/49€765k€874k▲

Amounts payable after more than one year17€275k€503k▲

Financial debts170/4-€228k

Other amounts payable178/9€275k€275k=

Amounts payable within one year42/48€490k€369k▼

Current portion of amounts payable after more than one year42€2k€40k▲

Financial debts43€24k€62k▲

Credit institutions430/8€24k€62k▲

Trade debts44€151k€146k▼

Suppliers440/4€151k€146k▼

Taxes, remuneration and social security45€30k€73k▲

Taxes450/3€9k€27k▲

Remuneration and social security454/9€21k€46k▲

Other amounts payable47/48€283k€47k▼

Accrued charges and deferred income492/3€370€2k▲

Income statement Code20242025

Non-recurring operating income76A€53k-

Remuneration, social security and pensions62€29k€178k▲

Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€8k€52k▲

Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€17k€-17k▼

Other operating charges640/8€6k€32k▲

Non-recurring operating charges66A-€40k

Gross operating margin9900€104k€40k▼

Operating profit (loss)9901€43k€-245k▼

Financial income75/76B€2k€839▼

Recurring financial income75€2k€839▼

Financial charges65/66B€8k€25k▲

Recurring financial charges65€8k€25k▲

Profit (loss) for the period before taxes9903€36k€-270k▼

Income taxes67/77€9k€204▼

Profit (loss) for the period9904€27k€-270k▼

Profit (loss) for the period to be appropriated9905€27k€-270k▼

Appropriation of the result

Profit (loss) to be appropriated9906€25k€-270k▼

Profit (loss) brought forward from the previous period14P€-2k-

Transfer from equity791/2-€25k

Transfer to equity691/2€25k-

To other reserves6921€25k-

The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

All 7Financial 2Gazette 1Filings 4

Next filing, fiscal year 2026, expected by 31-07-2027

2026

09-09

State Gazette act Board meeting · Registered-office move

Board meeting · Registered-office move2 facts ▸

Board meeting, 2026-08-31
Registered-office move, rue de l'avenir, 12 à 4890 THIMISTER-CLERMONT

23-07

NBB filing Annual accounts filed

fiscal year 2025 · micro schema

2025

31-12

Financial Weakest financial yearnet €-270k ▼1102%

Net result drops to €-270k, the lowest in the series.

30-09

NBB filing Annual accounts filed

fiscal year 2024 · micro schema · 61 days late

2024

31-12

Financial Back to profitnet €27k

Net result €27k after one loss-making year.

31-08

NBB filing Annual accounts filed

fiscal year 2023 · micro schema · 31 days late

2023

15-09

NBB filing Annual accounts filed

fiscal year 2022 · micro schema · 46 days late

Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors

no sitting director, no change since 2026

We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.

07-01-2026 DEVOGE Marc: Resigned as Director

06-09-2025 SOUD BARKANI: Resigned as Director

25-01-2023 Boelen Serge Dominik K.: Resigned as Director

Location & real-estate footprint

Registered office, Thimister-Clermont · 1 establishment unit since 2022

establishment The establishment unit on the map

Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Rue de l'Avenir 124890 Thimister-Clermont

Ground area

9,551 m²

Building footprint